Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice - PubMed (original) (raw)
Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice
Jonathan W Snow et al. J Immunol. 2003.
Abstract
STAT5 has previously been reported to be dispensable for the maintenance of tolerance in vivo. However, in examining hemopoiesis in mice lacking both isoforms of STAT5, STAT5A, and STAT5B, we noted that a subset of these mice demonstrated dramatic alterations in several bone marrow progenitor populations concomitant with lymphocytic infiltration of the bone marrow. In addition, cellular infiltration affecting the colon, liver, and kidney was observed in these mice. Survival analysis revealed that STAT5A/5B(-/-) mice exhibited early death. The increased mortality and the pathology affecting multiple organs observed in these mice were abrogated on the recombination-activating gene 1(-/-) background. In light of the similarities between STAT5A/5B-deficient mice and mice unable to signal through the IL-2R, we hypothesized that the tolerizing role of STAT5A/5B was triggered via activation of the IL-2R. In agreement with this, we found that IL-2Rbeta chain-deficient mice exhibited similar hemopoietic abnormalities. Because IL-2 signaling is thought to contribute to tolerance through maintenance of a CD4(+)CD25(+) regulatory T cell population, we examined these cells and observed a numerical reduction in STAT5A/5B(-/-) mice along with a higher rate of apoptosis. These data provide strong evidence for a requirement for STAT5 in the maintenance of tolerance in vivo.
Similar articles
- Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
Antov A, Yang L, Vig M, Baltimore D, Van Parijs L. Antov A, et al. J Immunol. 2003 Oct 1;171(7):3435-41. doi: 10.4049/jimmunol.171.7.3435. J Immunol. 2003. PMID: 14500638 - The role of Fas in the immune system biology of IL-2R alpha knockout mice: interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis.
Sharma R, Bagavant H, Jarjour WN, Sung SS, Ju ST. Sharma R, et al. J Immunol. 2005 Aug 1;175(3):1965-73. doi: 10.4049/jimmunol.175.3.1965. J Immunol. 2005. PMID: 16034141 - Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice.
Snow JW, Abraham N, Ma MC, Goldsmith MA. Snow JW, et al. Exp Hematol. 2003 Dec;31(12):1247-52. doi: 10.1016/j.exphem.2003.08.013. Exp Hematol. 2003. PMID: 14662331 - The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.
Lin JX, Leonard WJ. Lin JX, et al. Oncogene. 2000 May 15;19(21):2566-76. doi: 10.1038/sj.onc.1203523. Oncogene. 2000. PMID: 10851055 Review. - IL-2 and autoimmune disease.
Schimpl A, Berberich I, Kneitz B, Krämer S, Santner-Nanan B, Wagner S, Wolf M, Hünig T. Schimpl A, et al. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):369-78. doi: 10.1016/s1359-6101(02)00022-9. Cytokine Growth Factor Rev. 2002. PMID: 12220550 Review.
Cited by
- Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.
Wang C, Xiao Y, Lao M, Wang J, Xu S, Li R, Xu X, Kuang Y, Shi M, Zou Y, Wang Q, Liang L, Zheng SG, Xu H. Wang C, et al. JCI Insight. 2020 Sep 17;5(18):e135935. doi: 10.1172/jci.insight.135935. JCI Insight. 2020. PMID: 32938830 Free PMC article. - Interleukin-2 receptor signaling: at the interface between tolerance and immunity.
Malek TR, Castro I. Malek TR, et al. Immunity. 2010 Aug 27;33(2):153-65. doi: 10.1016/j.immuni.2010.08.004. Immunity. 2010. PMID: 20732639 Free PMC article. Review. - LAT-mediated signaling in CD4+CD25+ regulatory T cell development.
Koonpaew S, Shen S, Flowers L, Zhang W. Koonpaew S, et al. J Exp Med. 2006 Jan 23;203(1):119-29. doi: 10.1084/jem.20050903. Epub 2005 Dec 27. J Exp Med. 2006. PMID: 16380508 Free PMC article. - IL-2 family of cytokines in T regulatory cell development and homeostasis.
Malek TR, Yu A, Zhu L, Matsutani T, Adeegbe D, Bayer AL. Malek TR, et al. J Clin Immunol. 2008 Nov;28(6):635-9. doi: 10.1007/s10875-008-9235-y. Epub 2008 Aug 26. J Clin Immunol. 2008. PMID: 18726679 - Targeting IL-2: an unexpected effect in treating immunological diseases.
Ye C, Brand D, Zheng SG. Ye C, et al. Signal Transduct Target Ther. 2018 Jan 19;3:2. doi: 10.1038/s41392-017-0002-5. eCollection 2018. Signal Transduct Target Ther. 2018. PMID: 29527328 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous